Replies to post #248351 on Biotech Values

[edcoolidge]

If you look back to the March 2020 market panic you'll see that ENTA was essentially unaffected, and that was before the announcement of EDP-235. ENTA had already sold off considerably in 2019 for unrelated reasons. Impossible to say for sure what would happen in a future hypothetical panic but it's not unprecedented that ENTA could be spared, especially after this year's already brutal sell off.

[WorstLuck]

After today's Treasury announcement with more weight on Bonds to Bills than previously, I'm more inclined to be cautious about the market in general.

So that was early August. I'm not making a call or time stamping anything because there has been "a recession coming in the next 6-9 months" for at least a year and a half. The market can still make new highs from here. It just continues to look right to be cautious.

$XBI is probably going to have another losing year. There should be plenty of tax loss selling over the next 2-3 months. Not sure how many of those names are worth looking at but a few should have outsized gains to start next year. I've looked at some screens of potential names and it's not as attractive as in past years.

Make your own judgments.